EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience

Nurettin Ay, Ramazan Danış

The Journal of Infection in Developing Countries · 2023

DOI: 10.3855/jidc.17956 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2023. Verfasst von Nurettin Ay und 1 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences University, Gazi Yaşargil Educational and Research Hospital, Department of General Surgery, Organ Transplant Center, Diyarbakır, Turk…. Hauptthemen laut MEDLINE: Kidney Transplantation, COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In this study, it was aimed to investigate the clinical (real-life) impact of the vaccination protocol on patients undergoing kidney transplantation during the COVID-19 pandemic. Methodology: A total of 260 patients who underwent kidney transplantation between June 2012 and May 2022 were retrospectively evaluated. Patients chose vaccination Sinovac-CoronaVac (CoronaVac) and/or BNT162b2 (Biontech), the first vaccine available in the country) in line with the regulations and recommendations of the Ministry of Health. The relationship between vaccination, hospitalization, and mortality in cases diagnosed with COVID-19 was investigated. The prevalence of COVID-19 in patients, the rate of hospital admission, and the mortality of patients before and after the national vaccination program were examined.

Results

The study included a total of 260 kidney transplant patients (Female, n = 107 (41%); male, n = 153 (59%). The mean age of patients was 38.42 (11-75). A total of 108 (41.5%) patients were diagnosed with COVID-19. Seven (6.5%) patients died and 221 (85%) patients were vaccinated after the national vaccination program. During the follow-up period, 108 (41.5%) patients were diagnosed with COVID-19. There was no significant difference in terms of hospitalization between two groups. However, there was a significant difference in terms of admission to intensive care unit and mortality (p < 0.001).

Conclusions

The majority of cases that died were unvaccinated. However, repeated vaccinations may not adequately protect all transplant recipients. There is a need to develop personalized treatment and prevention strategies in transplantation cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCOVID-19HumansFemaleMaleBNT162 VaccineCOVID-19 VaccinesPandemicsRetrospective StudiesVaccination

Stichwörter der Autor:innen

COVID-19kidney transplant recipientsvaccine

Substanzen

BNT162 VaccineCOVID-19 Vaccines

Autor:innen und Institutionen

  • Health Sciences University, Gazi Yaşargil Educational and Research Hospital, Department of General Surgery, Organ Transplant Center, Diyarbakır, Turkey.
  • Health Sciences University, Gazi Yaşargil Educational and Research Hospital, Department of Nephrology, Organ Transplant Center, Diyarbakır, Turkey.

Zitieren

APA

Ay, N., & Danış, R. (2023). Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17956

Vancouver

Ay N, Danış R. Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience. The Journal of Infection in Developing Countries. 2023. doi:10.3855/jidc.17956

BibTeX
@article{Ay2023,
  author = {Ay, Nurettin and Danış, Ramazan},
  title = {Real-life outcomes of COVID-19 vaccination in kidney transplant patients: a single-center experience},
  journal = {The Journal of Infection in Developing Countries},
  year = {2023},
  doi = {10.3855/jidc.17956}
}
Kostenlos starten →